These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 32070865)

  • 21. Hybrid mesoporous silica nanospheres modified by poly (NIPAM-co-AA) for drug delivery.
    Zhang K; Zhou D; Wang Z; Zhang Y; He P
    Nanotechnology; 2019 Aug; 30(35):355604. PubMed ID: 31071691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesoporous silica nanobeans dual-functionalized with AIEgens and leaning pillar[6]arene-based supramolecular switches for imaging and stimuli-responsive drug release.
    Li X; Han J; Qin J; Sun M; Wu J; Lei L; Li J; Fang L; Yang YW
    Chem Commun (Camb); 2019 Dec; 55(94):14099-14102. PubMed ID: 31641718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A robust pH-sensitive unimolecular dendritic nanocarrier that enables targeted anti-cancer drug delivery via GLUT transporters.
    Kumar P; Paknikar KM; Gajbhiye V
    Colloids Surf B Biointerfaces; 2018 Nov; 171():437-444. PubMed ID: 30075419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spatial, Temporal, and Dose Control of Drug Delivery using Noninvasive Magnetic Stimulation.
    Chen W; Cheng CA; Zink JI
    ACS Nano; 2019 Feb; 13(2):1292-1308. PubMed ID: 30633500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carboxylated chitosan-mediated improved efficacy of mesoporous silica nanoparticle-based targeted drug delivery system for breast cancer therapy.
    Lohiya G; Katti DS
    Carbohydr Polym; 2022 Feb; 277():118822. PubMed ID: 34893239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.
    Tarn D; Ashley CE; Xue M; Carnes EC; Zink JI; Brinker CJ
    Acc Chem Res; 2013 Mar; 46(3):792-801. PubMed ID: 23387478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biotemplated Hollow Mesoporous Silica Particles as Efficient Carriers for Drug Delivery.
    Heidari Nia M; Koshani R; Munguia-Lopez JG; Kiasat AR; Kinsella JM; van de Ven TGM
    ACS Appl Bio Mater; 2021 May; 4(5):4201-4214. PubMed ID: 35006833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted delivery of doxorubicin to mitochondria using mesoporous silica nanoparticle nanocarriers.
    Qu Q; Ma X; Zhao Y
    Nanoscale; 2015 Oct; 7(40):16677-86. PubMed ID: 26400067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X; Zhao Y; Ng KW; Zhao Y
    Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
    Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
    Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioresponsive mesoporous silica nanoparticles for triggered drug release.
    Singh N; Karambelkar A; Gu L; Lin K; Miller JS; Chen CS; Sailor MJ; Bhatia SN
    J Am Chem Soc; 2011 Dec; 133(49):19582-5. PubMed ID: 21981330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Superior doxorubicin cellular delivery effect established by optically active mesoporous silica nanoparticles.
    Wang L; Yu D; Li D; Li J
    Drug Deliv Transl Res; 2024 Nov; 14(11):3163-3172. PubMed ID: 38381319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
    Guo XL; Kang XX; Wang YQ; Zhang XJ; Li CJ; Liu Y; Du LB
    Acta Biomater; 2019 Jan; 84():367-377. PubMed ID: 30528609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. pH and Ultrasound Dual-Responsive Polydopamine-Coated Mesoporous Silica Nanoparticles for Controlled Drug Delivery.
    Li X; Xie C; Xia H; Wang Z
    Langmuir; 2018 Aug; 34(34):9974-9981. PubMed ID: 30056720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
    Hu X; Wang Y; Peng B
    Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amino-functionalized mesoporous silica nanoparticles as efficient carriers for anticancer drug delivery.
    He Y; Luo L; Liang S; Long M; Xu H
    J Biomater Appl; 2017 Oct; 32(4):524-532. PubMed ID: 28776488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In situ biodegradable crosslinking of cationic oligomer coating on mesoporous silica nanoparticles for drug delivery.
    Wang Y; Wang J; Yang Y; Sun Y; Yuan Y; Li Y; Liu C
    Colloids Surf B Biointerfaces; 2017 May; 153():272-279. PubMed ID: 28279933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. pH-sensitive poly(glutamic acid) grafted mesoporous silica nanoparticles for drug delivery.
    Zheng J; Tian X; Sun Y; Lu D; Yang W
    Int J Pharm; 2013 Jun; 450(1-2):296-303. PubMed ID: 23598077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPR-dCas9-Guided and Telomerase-Responsive Nanosystem for Precise Anti-Cancer Drug Delivery.
    Ma Y; Mao G; Wu G; Cui Z; Zhang XE; Huang W
    ACS Appl Mater Interfaces; 2021 Feb; 13(7):7890-7896. PubMed ID: 33513005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. pH-Sensitive nanoparticles based on amphiphilic imidazole/cholesterol modified hydroxyethyl starch for tumor chemotherapy.
    Xu Z; Yang D; Long T; Yuan L; Qiu S; Li D; Mu C; Ge L
    Carbohydr Polym; 2022 Feb; 277():118827. PubMed ID: 34893244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.